Cargando…

N-acetyltransferase gene polymorphisms & plasma isoniazid concentrations in patients with tuberculosis

BACKGROUND & OBJECTIVES: Variations in the N-acetyltransferase (NAT2) gene among different populations could affect the metabolism and disposition of isoniazid (INH). This study was performed to genotype NAT2 gene polymorphisms in tuberculosis (TB) patients from Chennai, India, and compare plasm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hemanth Kumar, A. K., Ramesh, K., Kannan, T., Sudha, V., Haribabu, Hemalatha, Lavanya, J., Swaminathan, Soumya, Ramachandran, Geetha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460557/ https://www.ncbi.nlm.nih.gov/pubmed/28574024 http://dx.doi.org/10.4103/ijmr.IJMR_2013_15

Ejemplares similares

Intrapatient variability in plasma rifampicin & isoniazid in tuberculosis patients
por: Kumar, A. K. Hemanth, et al.
Publicado: (2018)

Food significantly reduces plasma concentrations of first-line anti-tuberculosis drugs
por: Kumar, Agibothu Kupparam Hemanth, et al.
Publicado: (2017)

Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosis
por: Mave, Vidya, et al.
Publicado: (2017)

Correlation of N-acetyltransferase 2 genotype and acetylation status with plasma isoniazid concentration and its metabolic ratio in ethiopian tuberculosis patients
por: Sileshi, Tesemma, et al.
Publicado: (2023)

Pharmacokinetics of rifampicin, isoniazid & pyrazinamide during daily & intermittent dosing: A preliminary study
por: Ramachandran, Geetha, et al.
Publicado: (2023)

Correlation of N-Acetyltransferase 2 Genotype with Isoniazid Acetylation in Polish Tuberculosis Patients
por: Zabost, Anna, et al.
Publicado: (2013)

Drug Concentration Thresholds Predictive of Therapy Failure and Death in Children With Tuberculosis: Bread Crumb Trails in Random Forests
por: Swaminathan, Soumya, et al.
Publicado: (2016)

Lack of association between plasma levels of non-nucleoside reverse transcriptase inhibitors & virological outcomes during rifampicin co-administration in HIV-infected TB patients
por: Ramachandran, Geetha, et al.
Publicado: (2013)

Effect of rifampicin & isoniazid on the steady state pharmacokinetics of moxifloxacin
por: Ramachandran, Geetha, et al.
Publicado: (2012)

Role of pharmacogenomics in the treatment of tuberculosis: a review
por: Ramachandran, Geetha, et al.
Publicado: (2012)

Influence of N-acetyltransferase 2 (NAT2) genotype/single nucleotide polymorphisms on clearance of isoniazid in tuberculosis patients: a systematic review of population pharmacokinetic models
por: Thomas, Levin, et al.
Publicado: (2022)

N-Acetyltransferase 2 Genotypes among Zulu-Speaking South Africans and Isoniazid and N-Acetyl-Isoniazid Pharmacokinetics during Antituberculosis Treatment
por: Mthiyane, Thuli, et al.
Publicado: (2020)

Can Urine Lamivudine Be Used to Monitor Antiretroviral Treatment Adherence?
por: Kumar, Agibothu K Hemanth, et al.
Publicado: (2006)

Arylamine N-acetyltransferase 2 genotype-dependent N-acetylation of isoniazid in cryopreserved human hepatocytes
por: Doll, Mark A., et al.
Publicado: (2017)

Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia
por: Getahun, Muluwork, et al.
Publicado: (2022)

The Influence of NAT2 Genotypes on Isoniazid Plasma Concentration of Pulmonary Tuberculosis Patients in Southern Thailand
por: Ungcharoen, Usanee, et al.
Publicado: (2020)

Dyslipidemia among HIV-infected Patients with Tuberculosis Taking Once-daily Nonnucleoside Reverse-Transcriptase Inhibitor–Based Antiretroviral Therapy in India
por: Padmapriyadarsini, Chandrasekaran, et al.
Publicado: (2011)

Real-life isoniazid and rifampicin plasma concentrations in children: a tool for therapeutic drug monitoring of tuberculosis
por: Tersigni, Chiara, et al.
Publicado: (2021)

Whole-Genome Sequencing to Identify Missed Rifampicin and Isoniazid Resistance Among Tuberculosis Isolates—Chennai, India, 2013–2016
por: Tamilzhalagan, Sembulingam, et al.
Publicado: (2021)

Effectiveness of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected adults in programme setting
por: Padmapriyadarsini, C., et al.
Publicado: (2020)

Suboptimal Antituberculosis Drug Concentrations and Outcomes in Small and HIV‐Coinfected Children in India: Recommendations for Dose Modifications
por: Guiastrennec, Benjamin, et al.
Publicado: (2018)

Polymorphism of human acetyltransferases.
por: Meyer, U A
Publicado: (1994)

Role of LTA4H Polymorphism in Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome Occurrence and Clinical Severity in Patients Infected with HIV
por: Narendran, Gopalan, et al.
Publicado: (2016)

Dose of Isoniazid in Renal Disease for Treatment of Tuberculosis
por: Sarma, G. R. K.
Publicado: (2022)

Binding of activated isoniazid with acetyl-CoA carboxylase from Mycobacterium tuberculosis
por: Unissa, Ameeruddin Nusrath, et al.
Publicado: (2011)

Impact of Isoniazid Resistance-Conferring Mutations on the Clinical Presentation of Isoniazid Monoresistant Tuberculosis
por: Dantes, Raymund, et al.
Publicado: (2012)

Clinical Characteristics and Treatment Outcomes of Patients with Low- and High-Concentration Isoniazid-Monoresistant Tuberculosis
por: Wang, Tsai-Yu, et al.
Publicado: (2014)

Treatment of isoniazid-resistant pulmonary tuberculosis
por: Kim, Yee Hyung, et al.
Publicado: (2008)

Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
por: Jhun, Byung Woo, et al.
Publicado: (2020)

Antituberculosis Drug-Induced Hepatotoxicity in IranianTuberculosis Patients: Role of Isoniazid Metabolic Polymorphism
por: Sistanizad, Mohammad, et al.
Publicado: (2011)

Arylamine N-acetyltransferase 2 Polymorphisms and the Risk of Endometriosis
por: Fayez, Diman, et al.
Publicado: (2018)

Arylamine N-acetyltransferase 2 Polymorphisms and the Risk of Endometriosis
por: Barra, Fabio, et al.
Publicado: (2018)

Plasma Concentrations of sTREM-1 as Markers for Systemic Adverse Reactions in Subjects Treated With Weekly Rifapentine and Isoniazid for Latent Tuberculosis Infection
por: Wang, Tsai-Yu, et al.
Publicado: (2022)

Wild-Type MIC Distribution for Re-evaluating the Critical Concentration of Anti-TB Drugs and Pharmacodynamics Among Tuberculosis Patients From South India
por: Dusthackeer, Azger, et al.
Publicado: (2020)

Association of Cytochrome P450 2E1 and N-Acetyltransferase 2 Genotypes with Serum Isoniazid Level and Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Cross-Sectional Study
por: Pourmohamadi, Nasir, et al.
Publicado: (2023)

Electrospun Orodispersible Films of Isoniazid for Pediatric Tuberculosis Treatment
por: Chachlioutaki, Konstantina, et al.
Publicado: (2020)

Differential Culturability of Mycobacterium tuberculosis in Culture-Negative Sputum of Patients With Pulmonary Tuberculosis and in a Simulated Model of Dormancy
por: Dusthackeer, Azger, et al.
Publicado: (2019)

Perceptions of Private Medical Practitioners on Tuberculosis Notification: A Study from Chennai, South India
por: Thomas, Beena Elizabeth, et al.
Publicado: (2016)

N-acetyltransferase 2 genetic polymorphisms and anti-tuberculosis-drug-induced liver injury: a correlation study
por: Cheng, Fang, et al.
Publicado: (2023)

Isoniazid-Resistant Tuberculosis, Taiwan, 2000–2010
por: Lai, Chih-Cheng, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_agga0ro0nromqrh8cvjf2f43en